2,4-Dimethoxyphenethylamine

Last updated
2,4-Dimethoxyphenethylamine
2,4-Dimethoxyphenethylamine.svg
Clinical data
Other names2,4-DMPEA; DMPEA-3; 24; 24DMP
Drug class Serotonin 5-HT2A receptor agonist
ATC code
  • None
Identifiers
  • 2-(2,4-dimethoxyphenyl)ethanamine
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C10H15NO2
Molar mass 181.235 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1)CCN)OC
  • InChI=1S/C10H15NO2/c1-12-9-4-3-8(5-6-11)10(7-9)13-2/h3-4,7H,5-6,11H2,1-2H3
  • Key:YDTQAPOROITHCN-UHFFFAOYSA-N

2,4-Dimethoxyphenethylamine (2,4-DMPEA), also known as DMPEA-3, is a drug of the phenethylamine family related to the psychedelic drug mescaline (3,4,5-trimethoxyphenethylamine). [1] [2] [3] It is one of the positional isomers of dimethoxyphenethylamine. [1]

Contents

The in-vitro metabolism of 2,3-DMPEA and its effects on cat behavior have been studied. [1] [2] [3] The drug is known to act as a low-potency partial agonist of the serotonin 5-HT2A receptor (Ki = 202–999 nM; EC50 Tooltip half-maximal effective concentration = 832–4,034 nM; Emax Tooltip maximal efficacy = 67–83%). [4] [5] The effects of 2,4-DMPEA in humans have not been reported and are unknown. [1]

2,4-DMPEA was first described in the scientific literature by at least 1964. [1] [2] It was included as an entry in Alexander Shulgin's 2011 book The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds . [1]

NBOMe and NBOH derivatives with potent serotonin 5-HT2A receptor agonism, such as 24-NBOMe and 24-NBOH, have been synthesized and studied. [4] [5]

See also

References

  1. 1 2 3 4 5 6 Shulgin A, Manning T, Daley PF (2011). "#47. 2,4-DMPEA". The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds . Vol. 1. Berkeley, CA: Transform Press. pp. 82–83. ISBN   978-0-9630096-3-0. OCLC   709667010.
  2. 1 2 3 Clark LC, Benington F, Morin RD (October 1964). "The enzymatic oxidative deamination and effect on cat behavior mescaline and structurally-related beta-phenethylamines". Ala J Med Sci. 1: 417–429. PMID   14230671.
  3. 1 2 Clark LC, Benington F, Morin RD (May 1965). "The effects of ring-methoxyl groups on biological deamination of phenethylamines". J Med Chem. 8 (3): 353–355. doi:10.1021/jm00327a016. PMID   14323146.
  4. 1 2 Braden MR, Parrish JC, Naylor JC, Nichols DE (December 2006). "Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists". Mol Pharmacol. 70 (6): 1956–1964. doi:10.1124/mol.106.028720. PMID   17000863.
  5. 1 2 Braden MR (2007). Towards a biophysical understanding of hallucinogen action (Ph.D. thesis). Purdue University. ProQuest   304838368.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.